Needham Reiterates Buy on Datadog, Maintains $105 Price Target
Needham analyst Mike Cikos reiterates Datadog (NASDAQ:DDOG) with a Buy and maintains $105 price target.
Wells Fargo Maintains Equal-Weight on FedEx, Raises Price Target to $240
Wells Fargo analyst Allison Poliniak maintains FedEx (NYSE:FDX) with a Equal-Weight and raises the price target from $225 to $240.
RBC Capital Maintains Underperform on Lennar, Raises Price Target to $85
RBC Capital analyst Mike Dahl maintains Lennar (NYSE:LEN) with a Underperform and raises the price target from $76 to $85.
Oppenheimer Downgrades DigitalOcean Holdings to Perform, Announces $40 Price Target
Oppenheimer analyst Timothy Horan downgrades DigitalOcean Holdings (NYSE:DOCN) from Outperform to Perform and announces $40 price target.
Exane BNP Paribas Upgrades Alphabet to Outperform, Announces $123 Price Target
Exane BNP Paribas analyst Stefan Slowinski upgrades Alphabet (NASDAQ:GOOGL) from Neutral to Outperform and announces $123 price target.
Barclays Maintains Equal-Weight on G-III Apparel Group, Raises Price Target to $15
Barclays analyst Paul Kearney maintains G-III Apparel Group (NASDAQ:GIII) with a Equal-Weight and raises the price target from $13 to $15.
Tigress Financial Reiterates Buy on Cisco Systems, Maintains $73 Price Target
Tigress Financial analyst Ivan Feinseth reiterates Cisco Systems (NASDAQ:CSCO) with a Buy and maintains $73 price target.
Biophytis Changes Ratio Under ADR Program To One ADS Representing 100 Shares From One ADS Representing 10 Shares Effective March 30
Biophytis SA ((NasdaqCM:BPTS, PARIS:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes